Yuxiang Han

843 total citations
38 papers, 690 citations indexed

About

Yuxiang Han is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Yuxiang Han has authored 38 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 6 papers in Psychiatry and Mental health. Recurrent topics in Yuxiang Han's work include Neuroscience and Neuropharmacology Research (8 papers), Mitochondrial Function and Pathology (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Yuxiang Han is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Mitochondrial Function and Pathology (5 papers) and Anesthesia and Neurotoxicity Research (4 papers). Yuxiang Han collaborates with scholars based in China and United States. Yuxiang Han's co-authors include Zhibo Liu, Mengxin Xu, Dongban Duan, Yang Xu, Haoyue Hu, Chang Gu, Hong-Yan Gu, Ning Wu, Hui Liu and Zhengchu Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Brain Research.

In The Last Decade

Yuxiang Han

35 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxiang Han China 15 291 116 92 86 83 38 690
Zhongchan Sun China 17 351 1.2× 72 0.6× 84 0.9× 97 1.1× 52 0.6× 33 782
Kefu Yu China 16 317 1.1× 102 0.9× 103 1.1× 61 0.7× 79 1.0× 40 830
Eric Kampmann Germany 13 211 0.7× 135 1.2× 90 1.0× 43 0.5× 46 0.6× 24 569
Xingdang Liu China 11 144 0.5× 163 1.4× 45 0.5× 111 1.3× 65 0.8× 48 524
Michael Gallagher Ireland 16 388 1.3× 232 2.0× 51 0.6× 116 1.3× 86 1.0× 30 941
Sosuke Miyoshi Japan 16 328 1.1× 117 1.0× 55 0.6× 110 1.3× 78 0.9× 37 771
Yinghua Li China 17 370 1.3× 119 1.0× 36 0.4× 27 0.3× 71 0.9× 40 795
Shuang Ding China 21 438 1.5× 122 1.1× 78 0.8× 79 0.9× 25 0.3× 88 983
Hye-Hyun Ahn United States 9 333 1.1× 102 0.9× 54 0.6× 53 0.6× 23 0.3× 9 784
Chien‐Chih Ke Taiwan 15 369 1.3× 89 0.8× 62 0.7× 37 0.4× 36 0.4× 48 654

Countries citing papers authored by Yuxiang Han

Since Specialization
Citations

This map shows the geographic impact of Yuxiang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Han more than expected).

Fields of papers citing papers by Yuxiang Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Han. The network helps show where Yuxiang Han may publish in the future.

Co-authorship network of co-authors of Yuxiang Han

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Han. A scholar is included among the top collaborators of Yuxiang Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Han. Yuxiang Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jing, Jing Jiang, Xinguang Chen, et al.. (2025). A non-inferiority randomized controlled study of Perampanel versus Oxcarbazepine monotherapy for post-stroke epilepsy. Seizure. 125. 172–178. 1 indexed citations
2.
Sun, Shulei, et al.. (2024). Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression. Frontiers in Neurology. 15. 1480854–1480854. 2 indexed citations
3.
Yang, Tingting, Yuanping Sun, Chunxiao Li, et al.. (2024). Efficacy and safety of Perampanel in the treatment of post stroke epilepsy: A multicenter, real-world study. Heliyon. 10(5). e26376–e26376. 2 indexed citations
5.
Wang, Fengju, Shuyan Zhang, Bingbing Song, & Yuxiang Han. (2023). Anxiety, depression, and quality of life in postoperative non-small cell lung cancer patients under the intervention of cognitive-behavioral stress management. Frontiers in Psychology. 14. 1138070–1138070. 10 indexed citations
6.
Han, Yuxiang, et al.. (2022). Skull involvement of SAPHO syndrome. Joint Bone Spine. 90(1). 105466–105466.
7.
Liu, Xiaoyun, et al.. (2021). Electrophysiological Evaluation in Identifying Unique Sleep Features Among Anti-LGI1 Encephalitis Patients During Active and Recovery Phase. Nature and Science of Sleep. Volume 13. 527–536. 4 indexed citations
8.
Yang, Simin, et al.. (2020). Isoflurane-induced expression of miR-140-5p aggravates neurotoxicity in diabetic rats by targeting SNX12. The Journal of Toxicological Sciences. 45(2). 69–76. 9 indexed citations
9.
Liu, Xiaoyun, et al.. (2020). The exploration of the spectrum of motor manifestations of anti-LGI1 encephalitis beyond FBDS. Seizure. 76. 22–27. 10 indexed citations
10.
Han, Yuxiang, et al.. (2020). miR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells. Neoplasma. 67(4). 773–781. 12 indexed citations
11.
Liang, Rui, et al.. (2019). Plasma amyloid beta level changes in aged mice with cognitive dysfunction following sevoflurane exposure. Experimental Gerontology. 129. 110737–110737. 8 indexed citations
12.
Chen, Junyi, Cong Li, Hui Liu, et al.. (2019). Side Chain Optimization Remarkably Enhances the in Vivo Stability of 18F-Labeled Glutamine for Tumor Imaging. Molecular Pharmaceutics. 16(12). 5035–5041. 15 indexed citations
13.
Han, Yuxiang, et al.. (2018). 2R,4R-APDC, a Metabotropic Glutamate Receptor Agonist, Reduced Neuronal Apoptosis by Upregulating MicroRNA-128 in a Rat Model After Seizures. Neurochemical Research. 43(3). 591–599. 6 indexed citations
14.
Xiang, Yuanyuan, Tao Gong, Junwei Wu, et al.. (2016). Subtypes evaluation of motor dysfunction in Parkinson’s disease using neuromelanin-sensitive magnetic resonance imaging. Neuroscience Letters. 638. 145–150. 29 indexed citations
15.
Yan, Feng, Yuxiang Han, Zelin Chen, et al.. (2016). Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9. G3 Genes Genomes Genetics. 6(8). 2517–2521. 19 indexed citations
16.
Liang, Fang Ting, Yuxiang Han, Hao Gao, et al.. (2015). Kaempferol Identified by Zebrafish Assay and Fine Fractionations Strategy from Dysosma versipellis Inhibits Angiogenesis through VEGF and FGF Pathways. Scientific Reports. 5(1). 14468–14468. 33 indexed citations
17.
18.
Han, Yuxiang, Ning Xie, Yaoming Xue, et al.. (2011). Impaired mitochondrial biogenesis in hippocampi of rats with chronic seizures. Neuroscience. 194. 234–240. 13 indexed citations
19.
Xu, Jingjing, Lili Cao, Yuxiang Han, et al.. (2010). Mitochondrial base excision repair pathway failed to respond to status epilepticus induced by pilocarpine. Neuroscience Letters. 474(1). 22–25. 10 indexed citations
20.
Li, Jie, et al.. (1995). Introducción a la teoría de la percolación, (I). Antecedentes y concepto. PubMed. 33(10). 121–124.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026